Loading company…
Shanghai Dunwill develops diagnostic products for cancer and metabolic diseases.
Shanghai Dunwill researches and develops diagnostic products, including tests for early liver cancer diagnosis and warnings of metastasis and recurrence. It also develops patient-derived tissue transplantation models to guide targeted therapy. The company was founded in 2006 and is based in Shanghai, China.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in